Clinical trial
Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid…
NCT00003288 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00003288 |
|---|---|
| Title | Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors |
| Official title | A Trial of Tirapazamine and Cyclophosphamide in Children With Refractory Solid Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Childhood Solid Tumor, Protocol Specific |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, cyclophosphamide, tirapazamine |
| Enrollment | 12 |
| Start date | Aug 1, 1998 |
| Primary completion | Jun 1, 2003 |
| First posted | Sep 13, 2004 |
| Last update posted | Feb 5, 2013 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: